The purpose of this study is to examine how different ways of sharing information about diabetes medication treatment options with patients can affect their choices and health.

• Have a diagnosis of type 2 diabetes mellitus of any duration; c-peptide test not required
• Use 1 or 2 oral hypoglycemic agents; not using insulin therapy
• Are not pregnant
• Have stable but inadequate glycemic control: both A1C at the time of eligibility and previous A1c within 6 months between 7-9.5%
• Recognize their primary care provider as their main diabetes care provider
• Do not have major barriers (i.e., severe hearing impairment, dementia, cannot communicate in English) to participate in shared decision-making (per provider?s assessment)
• Have no plans to relocate out of town in the next 6 months
• Enrolment is open to males and females of diverse racial backgrounds